Neurocognitive disorders Flashcards
Neurocognitive disorders: A new category in dsm-5
- Previously “organic mental disorders” and “cognitive disorders”
- “Neurocognitive disorders” because of overlap between dementia and amnestic disorders
- All disorders influenced by brain -> these disorders are categorized by this influence
- Brain cell regeneration?
Delirium:
often a temporary condition displayed as confusion and disorientation
Mild or major neurocognitive disorder:
a progressive condition marked by gradual deterioration of a range of cognitive abilities
Delirium: diagnostic criteria
- A. A disturbance in attention and awareness
- B. The disturbance develops over a short period of time, represents a change from baseline attention and awareness, and tends to fluctuate in severity during the course of a day
- C. An additional disturbance in cognition
- D. Disturbances in Criteria A and C are not better explained by another preexisting, established, or evolving neurocognitive disorder and do not occur in the context of a severely reduced level of arousal, such as coma
- E. There is evidence from the history, physical examination, or laboratory findings that the disturbance is a direct physiological consequence of another medical condition, substance intoxication, or withdrawal
Delirium: demographics and aetiology
- Prevalence: 20% of older adults admitted into acute care facilities/ hospitals
- Course
- Rapid onset
- Symptoms may vary over course of day
- Typically resides quickly
- Effects may be more long-lasting
- Aetiology
- Improper use of medications, high fever (in children), dementia, sign of end of life (in ¼ of cases), sleep deprivation, alcohol withdrawal, immobility, excessive stress
- Older people more likely to suffer delirium
Delirium: treatment and prevention
-
Treatment will depend on identified cause
- Substances or infection/injury
- First line of treatment: psychosocial intervention
- Provide reassurance to individual, give familiar personal belongings
- Delirium brought on by withdrawal from alcohol or other drugs is usually treated with haloperidol or other antipsychotic medications
- When case is unknown haloperidol or olanzapine are prescribed
- Prevention
- Proper medical care for illnesses and drug monitoring
Neurocognitive disorders
- Far more gradual decline in functioning
-
Major neurocognitive disorder (previously labelled dementia)
- Gradual deterioration of brain functioning that affects memory, judgment, language, other advanced cognitive processes
-
Mild neurocognitive disorder
- Early stages of cognitive decline
Mild neurocognitive disorder: diagnostic criteria
- A. Evidence of modest decline from a previous level of performance in one or more cognitive domains
- Concern of the individual, a knowledgeable informant, or the clinician that there has been a mild decline in functioning, and
- A modest impairment in cognitive performance, preferably documented by standardized neuropsychological testing or, in its absence, another quantified clinical assessment
- B. Cognitive deficits do not interfere with capacity for independence in everyday activities
- C. Cognitive deficits do not occur exclusively in the context of a delirium
- D. Cognitive deficits are not better explained by another mental disorder
- Specify whether due to:
- Alzheimer’s disease, frontotemporal lobe degeneration, etc.
Major neurocognitive disorder: diagnostic criteria
- A. Evidence of significant cognitive decline from a previous level of performance in one or more cognitive domains
- Concern of the individual, a knowledgeable informant, or the clinician that there has been a significant decline in cognitive functioning
- A substantial impairment in cognitive performance, preferably documented by standardized neuropsychological testing or, in its absence, another quantified clinical assessment
- B. Cognitive deficits interfere with independence in everyday activities
- C. The cognitive deficits do not occur exclusively in the context of a delirium
- D. Cognitive deficits not better explained by another mental disorder
- Specify whether due to:
- Alzheimer’s disease, frontotemporal lobe degeneration, etc.
Neurocognitive disorder: clinical description
Causes
- Will depend on which type person has
- Initial stages: impairment in memory for recent events, long-term still relatively intact
- Delusions can occur
- Emotional changes: depression, agitation, aggression, apathy
- Onset:
- Can develop at any age, more frequently seen in older adults
-
Causes (classes of neurocognitive disorders based on aetiology in DSM 5)
- Alzheimer’s disease
- Vascular disease
- Frontotemporal degeneration
- Traumatic brain injury
- Lewy body disease
- Parkinson’s disease
- HIV infection
- Substance use
- Huntington’s disease
- Prion disease
- Other medical condition
Agnosia:
common symptom of neurocognitive disorders where there is an inability to recognise and name objects
Facial agnosia
the inability to recognise even familiar faces
Neurocognitive disorder: Prevalence
- Will depend on which type, but in general prevalence increases with increasing age
- At age 65, 5%
- At age 85, 20% - 40%
- At age 100, 100%
- Rate of new cases doubles every 5 years after age 75 (aging population)
- More prevalent among women (due to Alzheimer’s disease)
Neurocognitive disorder due to Alzheimer’s disease: Diagnostic criteria
- A. The criteria are met for major or mild neurocognitive disorder
- B. There is insidious onset and gradual progression of impairment in one or more cognitive domains
- C. Criteria are met for either probable or possible Alzheimer’s disease as follows:
-
Major: Probable Alzheimer’s disease diagnosed if either one of following is present
- Evidence of a causative Alzheimer’s disease genetic mutation from family history or genetic testing
- All three of following present:
- Clear evidence of decline in memory and learning and at least one other cognitive domain
- Steadily progressive, gradual decline in cognition, without extended plateaus
- No evidence of mixed aetiology
-
Mild:
- Probable diagnosis if evidence of causative Alzheimer’s disease genetic mutation
- Possible diagnosis if no evidence of genetic mutation and all three present:
- Clear evidence of decline in memory and learning
- Steadily progressive, gradual decline in cognition, without extended plateaus
- No evidence of mixed aetiology
-
Major: Probable Alzheimer’s disease diagnosed if either one of following is present
- D. Disturbance not better explained by cerebrovascular disease, another neurodegenerative disease, the effects of a substance, or another mental, neurological, or systemic disorder
Neurocognitive disorder due to Alzheimer’s disease
Symptoms
Cognitive symptoms
Diagnosis
-
Symptoms
- Multiple cognitive deficits that develop gradually
- Predominant presentation: impairments of memory, orientation, judgment, reasoning
- Later stages: agitation, confusion, depression, anxiety, aggression
-
Specific cognitive symptoms:
- Aphasia (difficulty with language)
- Apraxia (impaired motor functioning)
- Agnosia (inability to recognise objects)
- Difficulties with executive functioning tasks
-
Diagnosis
- Used to be possible only post-mortem, but now looking at brain scans and spinal fluid assessments as possibilities
Neurocognitive disorder due to Alzheimer’s disease: demographics and course
- High prevalence in less educated persons
- Cognitive reserve hypothesis
- Higher prevalence in women
- Roughly same prevalence across ethnic groups
- Course:
- Cognitive deterioration slow during early and later stages
- Rapid during middle stages
- Average survival time is 8 years from diagnosis
- Onset typically in 60s or 70s, but can be earlier
- Aprox. 50% of neurocognitive disorders are a result of Alzheimer’s*
- Research confirms that that greater educational level may predict a delay in the observation of Alzheimer’s symptoms (suggests that education doesn’t prevent Alzheimer’s but creates buffer period of better functioning)*
Cognitive reserve hypothesis suggest that the more synapses a person develops throughout life, the more neuronal death must take place before the signs of dementia are obvious
Major or Mild Vascular neurocognitive disorder: Diagnostic criteria
- A. The criteria are met for major or mild neurocognitive disorder
- B. The clinical features are consistent with a vascular aetiology as suggested by either of the following:
- Onset of the cognitive deficits is temporally related to one or more cerebrovascular events
- Evidence for decline is prominent in complex attention
- C. There is evidence of the presence of cerebrovascular disease from history, physical examination, and/or neuroimaging considered sufficient to account for the neurocognitive deficits
- D. Symptoms are not better explained by another brain disease or systemic disorder. Probable vascular neurocognitive disorder is diagnosed if one of the following is present (otherwise diagnose “possible”)
- Clinical criteria are supported by neuroimaging evidence of significant parenchymal injury attributed to cerebrovascular disease (neuroimaging-supported)
- Neurocognitive syndrome is temporally related to one or more documented cerebrovascular events
- Both clinical and genetic evidence of cerebrovascular disease is present
Cerebrovascular
relating to the brain and its blood vessels
Vascular neurocognitive disorder
- Blood vessels in brain are blocked/damaged
-
Lower incidence rates than Alzheimer’s disease
- 70 – 75 years of age: 1.5%
- Over 80: 15%
-
Aetiology
- Stroke, cardiovascular disease
- Higher prevalence in men
-
Symptoms will depend on site of damage in brain
- Often includes decline in speed of information processing, executive functioning
- Onset is typically more sudden than Alzheimer’s type, probably because the disorder is result of a stroke, which inflicts brain damage immediately
Other Types of neurocognitive disorder
- Alzheimer’s disease
- Vascular disease
- Frontotemporal degeneration
- Traumatic brain injury
- Lewy body disease
- Parkinson’s disease
- HIV infection
- Substance use
- Huntington’s disease
- Prion disease
- Other medical condition
-
Traumatic brain injury
- Including chronic traumatic encephalopathy
-
Frontotemporal neurocognitive disorder
- An overarching term to categorise a variety of brain disorders that damage the frontal or temporal regions of the brain- areas that affect personality, language and behaviour
-
Pick’s disease
- Produces symptoms similar to that of Alzheimer’s disease
- Early onset (40s and 50s) last 5-10 years
-
Lewy body disease
- Microscopic deposits of protein that damage the brain cells over time
- Gradual onset including motor impairment
-
Parkinson’s disease
- Estimated that about 75% of people who survive more than 10 years with Parkinson’s disease develop neurocognitive disorder
- Primarily motor symptoms, stooped posture, speech soft and monotone
- HIV
-
Huntington’s disease
- Genetic disorder that initially affects motor movements
- Depression, anxiety, aphasia
-
Prion disease
- Caused by “prions”, proteins that can reproduce themselves and cause damage to brain cells leading to neurocognitive decline
- Can only be contracted through cannibalism or accidental inoculations from an infected person’s blood
- No known treatment, always fatal
-
Creutzfeldt-Jakob disease
- A type of prions disease
- Associated with mad cow’s disease
-
Substance/medication induced
- 7% of people dependent on alcohol meet the criteria for a neurocognitive disorder
- prolonged drug use and poor diet
Aetiology of neurocognitive disorder
Biological
Psychological and social
-
Biological
- Alzheimer’s disease
- Neurofibrillary tangles, amyloid plaques, and brain atrophy (examined after death)
- Brain atrophy itself cannot be deterministic if Alzheimer’s because it happens to many brains of older people
- Multiple genes seem to be involved
- Exercise may help reduce likelihood of disease, but only for some people
- Neurofibrillary tangles, amyloid plaques, and brain atrophy (examined after death)
- Head trauma
- Other causes: diabetes, high blood pressure, herpes
- Alzheimer’s disease
-
Psychological and social
- Lifestyle issues associated with cardiovascular pathology
- Lack of certain vitamins (B9 and B12)
- Occupational hazards contributing to head injury
Treatment of neurocognitive disorder
- Treatment prospects not good
- Brain cell regeneration?
- Goals of treatment:
- Try to prevent certain conditions that bring on neurocognitive disorder (substance abuse or strokes)
- Try to delay onset of symptoms to provide better quality of life
- Attempt to help affected individuals and caregivers to cope
- Intervention MUST target caregivers as well as afflicted persons
- High rates of depression and stress in this population
- Higher rates of neurocognitive disorders in caregivers
Biological treatments neurocognitive disorder
- Treatments available for some known causes (known infectious diseases, nutritional deficiencies and depression) if caught early
- Blood thinning meds to reduce blood clotting
- No known treatment for neurocognitive disorder caused by stroke, Parkinson’s, or Huntington’s diseases
- Alzheimer’s disease
-
Cholinesterase inhibitors (prevent breakdown of acetylcholine)
- Can have modest impact, but only in short-term
- Treat associated depression
- Vaccination in future?
-
Cholinesterase inhibitors (prevent breakdown of acetylcholine)
Psychosocial treatments neurocognitive disorders
- Target both individual and caregivers
-
Earlier stages
- Teach skills to compensate for lost abilities
- Cognitive stimulation
-
Later stages
- Severe impairment and dysregulated behaviour
- May not be able to engage in basic functions of living, may display inappropriate sexual and/or aggressive behaviour
- Teach communication skills?
- Caregivers should be taught how to deal with situation
- Bottom line:
- Best medications provide some recovery but do not prevent eventual decline
- Psychological interventions may help people cope with loss of cognitive abilities
- Provide psychological interventions to caregivers in early and late stages of decline
Other
- Overall, the outlook for slowing, but not stopping, the cognitive decline characterised by neurocognitive disorder is optimistic*
- Managed care and patient counselling have been successful in preventing delirium in older adults*
- Treatment for delirium depends on the cause of the episode and can include medications, psychosocial interventions or both*
- Delirium severely affects people’s memory, making tasks such as recalling ones own name difficult*
- The elderly population is at greatest risk of experiencing delirium resulting in improper use of medications*
- Various types of brain trauma, such as head injury or infection, have been linked to delirium*
- People who suffer from delirium appear to be confused or out of touch with their surroundings*
- Timmy’s elderly grandmother does not recognise her home any more (agnosia)*
- She can no longer form complete, coherent sentences (aphasia)*
- She no longer recognises Timmy when he visits, even though he is her only grandchild (facial agnosia)*
- Julian is a recovering alcoholic. When asked about his wild adventures as a young man, his stories usually end quickly because he can’t remember the whole tale. He even has to write down things he has to do in a notebook, otherwise, he’s likely to forget (substance-induced neurocognitive disorder)*
- Mr. Brown has suffered from a number of strokes but can still care for himself. His ability to remember important things, however, has been declining steadily for the past few years (vascular neurocognitive disorder)*
- A decline in cognitive functioning that is gradual and continuous and has been associated with neurofibrillary tangles and amyloid plaques (neurocognitive disorder due to Alzheimer’s disease)*